Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura
- PMID: 27060171
- DOI: 10.1182/blood-2016-03-703827
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura
Comment in
-
Adjuvant rituximab to prevent TTP relapse.Blood. 2016 Jun 16;127(24):2952-3. doi: 10.1182/blood-2016-04-710475. Blood. 2016. PMID: 27313327 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

